Muscle Spasticity Of Spinal Origin — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for muscle spasticity of spinal origin. 18 active patents protecting 1 drugs from 0+ originators. First major cliff: 2037. Daily refresh.

1
Approved drugs
18
Active US patents
62/100
Avg vulnerability
—
Annual revenue covered

Originators in Muscle Spasticity Of Spinal Origin

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating muscle spasticity of spinal origin. Each bar = one year. Y-axis scaled to peak year (10 patents).

2
37
10
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Lioresal
BACLOFEN
 — 18 62 — 2037-09-08

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11850225 Lioresal method of use 75 2041-09-29
11850225 Lioresal method of use 75 2041-09-29
11850225 Lioresal method of use 75 2041-09-29
11446246 Lioresal method of use 70 2037-09-08
11491125 Lioresal method of use 70 2041-09-29
11491125 Lioresal method of use 70 2041-09-29
11491125 Lioresal method of use 70 2041-09-29
10792262 Lioresal method of use 62 2039-07-29
10792262 Lioresal method of use 62 2039-07-29
10792262 Lioresal method of use 62 2039-07-29

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
11654124 Lioresal formulation 50 2039-07-29
11654124 Lioresal formulation 50 2039-07-29
11654124 Lioresal formulation 50 2039-07-29
11324696 Lioresal formulation 50 2037-09-29
11931328 Lioresal formulation 55 2039-07-29
11931328 Lioresal formulation 55 2039-07-29
11931328 Lioresal formulation 55 2039-07-29
10610502 Lioresal method of use 62 2039-08-30
10792262 Lioresal method of use 62 2039-07-29
10792262 Lioresal method of use 62 2039-07-29

Related